Comprehensive Guide to Myeloperoxidase (MPO) Testing

Myeloperoxidase (MPO) is a peroxidase enzyme most abundantly expressed in neutrophil granulocytes. In the field of clinical diagnostics and orthopedic-adjacent internal medicine, MPO has emerged as a critical biomarker for systemic inflammation, oxidative stress, and cardiovascular risk assessment. This guide provides an exhaustive overview of the MPO test, its clinical utility, and the implications of its findings for patient management.

1. What is Myeloperoxidase?

Myeloperoxidase is a heme-containing enzyme stored within the azurophilic granules of neutrophils. When these immune cells are activated, they release MPO into the extracellular space. Here, it catalyzes the production of hypohalous acids (like hypochlorous acid) from hydrogen peroxide and halide ions. While this process is essential for destroying pathogens, chronic or excessive MPO activity contributes to tissue damage, atherosclerotic plaque destabilization, and systemic oxidative stress.

The Role of MPO in Physiology

• Microbicidal Activity: Functions as the primary defense against bacterial and fungal infections.
• Inflammatory Modulation: Acts as a signaling molecule that promotes the recruitment of additional leukocytes.
• Vascular Impact: MPO modifies lipoproteins (specifically LDL), converting them into pro-atherogenic forms.

2. Technical Specifications and Mechanism

From a diagnostic perspective, the MPO test measures the concentration of this protein in serum or plasma. It is not merely a marker of infection; it is a marker of "activated" inflammation.

Biochemical Mechanism

When a neutrophil is triggered by a pathogen or vascular injury, it undergoes degranulation. MPO is released and interacts with hydrogen peroxide ($H_2O_2$) and chloride ($Cl^-$) to form hypochlorous acid ($HOCl$). This reaction is highly reactive and can cause oxidative damage to proteins, lipids, and DNA within the vascular wall.

3. Clinical Indications and Usage

The MPO test is utilized in several clinical scenarios, ranging from acute emergency medicine to chronic preventative care.

Cardiovascular Risk Assessment

The primary application of MPO testing is in the assessment of patients presenting with chest pain or suspected acute coronary syndrome (ACS). Elevated MPO levels are associated with:
* Plaque Instability: MPO promotes the degradation of the collagen cap of atherosclerotic plaques, increasing the risk of rupture.
* Prognostic Indicator: Patients with high MPO levels, even with negative troponin levels, have a significantly higher risk of future myocardial infarction.

Autoimmune and Inflammatory Conditions

MPO is also a target for Anti-Neutrophil Cytoplasmic Antibodies (ANCA). The presence of p-ANCA (perinuclear staining) is strongly associated with Microscopic Polyangiitis (MPA) and Eosinophilic Granulomatosis with Polyangiitis (EGPA).

Orthopedic and Systemic Considerations

In orthopedics, chronic systemic inflammation can impair bone healing and contribute to the development of periprosthetic joint infections (PJI). While MPO is not a standard pre-op test, it is increasingly studied as a marker for systemic inflammatory status in patients undergoing major joint replacement.

4. Reference Ranges and Interpretation

Reference ranges for MPO can vary based on the specific laboratory assay and the patient population. Clinicians must consult the specific reference interval provided by their diagnostic partner.

Typical Reference Ranges

Note: These values are illustrative and vary by assay.

Interpreting Abnormal Results

• Elevated Levels: Suggest active neutrophil activation, acute inflammation, or cardiovascular vulnerability.
• Decreased Levels: Generally rare and typically not clinically significant, though a complete deficiency (MPO deficiency) can lead to increased susceptibility to fungal infections (e.g., Candida).

5. Specimen Collection and Interfering Factors

To ensure the accuracy of the MPO test, strict adherence to collection protocols is mandatory.

Collection Guidelines

• Sample Type: Serum or EDTA plasma.
• Handling: Samples should be processed promptly. Hemolyzed samples are generally unacceptable as red blood cells contain peroxidases that can interfere with the assay.
• Stability: If the test cannot be performed immediately, samples should be frozen at -70°C.

Interfering Factors

• Hemolysis: Red blood cell rupture releases hemoglobin, which can falsely elevate results.
• Lipemia: High lipid content in the blood can interfere with light-based detection methods.
• Medications: Certain anti-inflammatory drugs (NSAIDs, corticosteroids) may lower MPO levels by suppressing neutrophil activity.
• Timing: Levels may fluctuate based on the timing of an acute inflammatory event.

6. Risks, Side Effects, and Contraindications

The MPO blood test is a non-invasive venipuncture procedure. Risks are minimal and standard for any blood draw:
* Bruising/Hematoma: At the site of puncture.
* Fainting: Vasovagal response.
* Infection: Extremely rare, occurring only if sterile technique is violated.

There are no physiological contraindications to the test itself. However, clinicians should be aware that the test is a "snapshot" and should be interpreted in the context of the patient’s full clinical picture.

7. Frequently Asked Questions (FAQ)

1. Is MPO testing the same as a CBC?
No. A CBC measures the number of neutrophils, while the MPO test measures the activity and concentration of a specific enzyme released by those cells.

2. Does an elevated MPO mean I have a heart attack?
Not necessarily. MPO is a marker of risk and inflammation. It must be interpreted alongside troponin levels, EKG results, and clinical symptoms.

3. Can I eat before the test?
Fasting is generally not required for MPO testing, but you should follow the specific instructions provided by your clinical laboratory.

4. What is MPO Deficiency?
MPO deficiency is a genetic condition where the body does not produce the enzyme. Most people are asymptomatic, but some may have a higher risk of severe fungal infections.

5. How does MPO affect my joints?
Chronic systemic inflammation, marked by elevated MPO, may contribute to systemic bone loss or poor recovery following orthopedic surgery.

6. Can stress increase MPO levels?
Acute physical stress triggers the immune system, which can transiently increase MPO levels.

7. How often should MPO be monitored?
Monitoring frequency is determined by the underlying condition (e.g., monitoring cardiovascular risk vs. monitoring vasculitis).

8. Are there any natural ways to lower MPO?
Managing chronic inflammation through diet (anti-inflammatory), regular exercise, and smoking cessation is generally recommended to lower systemic inflammatory markers.

9. Is the MPO test covered by insurance?
Coverage depends on the clinical indication. It is often covered when used to assess cardiovascular risk in high-risk patients.

10. What is the difference between MPO and CRP?
CRP (C-Reactive Protein) is a general marker of systemic inflammation. MPO is more specific to neutrophil-mediated oxidative stress and vascular injury.

Conclusion

The Myeloperoxidase (MPO) test serves as a powerful tool in the clinician’s arsenal for assessing cardiovascular risk and systemic inflammatory status. By understanding the mechanisms behind MPO and carefully interpreting results within the context of the patient’s health history, medical professionals can provide more targeted and effective care. As research continues to evolve, the role of MPO in orthopedic and surgical recovery is likely to gain further prominence.